PRTN3 and rheumatoid arthritis: The relevance of these findings for the development of RA has been most recently confirmed in two independent longitudinal studies, which have found that variable domain glycans are present in IgG ACPA up to 15 years before RA onset and their frequency increases progressively up until overt clinical disease (187, 188).